BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9187911)

  • 1. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.
    Hofmockel G; Riess S; Bassukas ID; Dämmrich J
    Eur Urol; 1997; 31(4):478-84. PubMed ID: 9187911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
    Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
    Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
    Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.
    Umekita Y; Ohi Y; Sagara Y; Yoshida H
    Int J Cancer; 2000 Nov; 89(6):484-7. PubMed ID: 11102891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of TGF-alpha, EGF and IL-6 in cultured renal tubular cells and renal cell carcinoma.
    Aoyagi T; Takishima K; Hayakawa M; Nakamura H
    Int J Urol; 1996 Sep; 3(5):392-6. PubMed ID: 8886918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cancer?
    Hofmockel G; Bassukas ID; Wittmann A; Dämmrich J
    Br J Urol; 1997 Jul; 80(1):11-7. PubMed ID: 9240173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of interleukin 6 (IL-6) and transforming growth factor alpha (TGF-alpha) expression in chromophobe renal cell carcinomas.
    Chudek J; Schullerus D; Wilhelm M; Kovacs G
    Br J Cancer; 1998 Nov; 78(9):1162-4. PubMed ID: 9820173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content.
    Artagaveytia N; Le Penven S; Falette N; Lucero R; Garófalo EG; Saez S
    J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):221-8. PubMed ID: 9191980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
    Thøgersen VB; Sørensen BS; Poulsen SS; Orntoft TF; Wolf H; Nexo E
    Cancer Res; 2001 Aug; 61(16):6227-33. PubMed ID: 11507076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer.
    Türkeri LN; Erton ML; Cevik I; Akdaş A
    Urology; 1998 Apr; 51(4):645-9. PubMed ID: 9586623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
    Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma.
    Walker C; Everitt J; Freed JJ; Knudson AG; Whiteley LO
    Cancer Res; 1991 Jun; 51(11):2973-8. PubMed ID: 2032234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.
    Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E
    J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer.
    Ravery V; Grignon D; Angulo J; Pontes E; Montie J; Crissman J; Chopin D
    Urol Res; 1997; 25(1):9-17. PubMed ID: 9079740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
    Friess H; Fukuda A; Tang WH; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler MW
    World J Surg; 1999 Oct; 23(10):1010-8. PubMed ID: 10512940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
    Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
    J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
    Jung M; Lee C; Park JH; Moon KC
    Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
    Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
    Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
    Umekita Y; Enokizono N; Sagara Y; Kuriwaki K; Takasaki T; Yoshida A; Yoshida H
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):345-51. PubMed ID: 1348890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.